论文部分内容阅读
作者选择了1993年1月1日～1994年4月30日为体外受精(IVF)或配子输卵管内移植(GIFT)而诱导排卵病人,于黄体中期给与Leaprolide 1mg SC1/d,完成垂体降调,于月经第5d,给与Metrodin 150～300IU 1/d,刺激卵泡发育,5d后监测血清E_2及阴道超声检查卵泡发育。当有≥3个卵泡直径≥17mm时,给与人绒毛膜促性腺激素(hCG),36h后,腹腔镜下抽吸腹腔液(PF)及穿刺卵泡取卵泡液(FF)(行GIFT者)或超声波引导下抽吸卵泡(行IVF者),麻醉前采集血清
The authors chose to inoculate in vitro fertilization (IVF) or gametocyte intragluarotransplantation (GIFT) on January 1, 1993 to April 30, 1994 to induce ovulation in the mid luteal phase of Leprolide 1mg SC1 / d, complete pituitary down regulation , On the 5th day of menstruation, 150 ~ 300IU 1 / d was given to Metrodin to stimulate follicular development. After 5 days, serum E_2 and vaginal ultrasound were examined for follicular development. When ≥3 follicles were ≥17mm in diameter, human chorionic gonadotropin (hCG) was administered. After 36h, peritoneal aspiration of peritoneal fluid (PF) and follicular follicle (FF) (GIFT) Or ultrasound-guided follicle aspiration (line IVF), serum before anesthesia